Apolipoprotein Testing Market Growth Forecast: Market Size, Key Trends And Emerging Opportunities Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Apolipoprotein Testing Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The apolipoprotein testing market size has experienced significant expansion in recent years. This market is forecasted to grow from $3.11 billion in 2025 to $3.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. The market’s historical growth can be attributed to the increasing occurrence of cardiovascular diseases, the wider embrace of lipid testing protocols, the proliferation of diagnostic laboratory networks, rising awareness about preventive healthcare, and the widespread availability of standardized apolipoprotein assays.
The apolipoprotein testing market is anticipated to show significant expansion over the next few years. It is projected to achieve a value of $4.09 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is driven by factors such as an escalating need for precise cardiovascular diagnostics, greater incorporation of molecular diagnostics into routine examinations, the expansion of personalized medicine strategies, increasing investments in automated diagnostic technologies, and a heightened emphasis on early disease risk stratification. Prominent trends expected in this period include the increased adoption of advanced lipid risk assessment tests, a rising demand for preventive cardiovascular diagnostics, enhanced integration of genetic and protein testing, the proliferation of automated immunoassay platforms, and a concentrated focus on individualized cardiac risk profiling.
Get A Free Sample Report With In-Depth Market Insights:
Apolipoprotein Testing Market Growth Factors Behind Sustained Expansion
The expanding occurrence of cardiovascular diseases is projected to drive the growth of the apolipoprotein testing market in the future. Cardiovascular disease (CVD) encompasses conditions impacting the heart and blood vessels, leading to serious events like heart attacks, strokes, and peripheral vascular disease. The surge in cardiovascular disorders is attributable to factors such as poor dietary practices, escalating obesity rates, and an aging population. Apolipoproteins, including ApoA-I and ApoB, play a vital role in transporting lipids within the blood. Measuring their levels aids in evaluating cardiovascular disease risk and customizing lipid-lowering therapies for effective management. For instance, data from the American Heart Association in January 2024 indicated that the age-adjusted mortality rate from cardiovascular disease increased to 233.3 per 100,000, marking a 4.0% rise from the prior year’s rate of 224.4 per 100,000, which itself followed a 4.6% increase in 2023. This marked the first such rise observed in many years. Consequently, the growing incidence of cardiovascular diseases is a key factor propelling the apolipoprotein testing market.
Apolipoprotein Testing Market Segments: Where Is Growth Concentrated?
The apolipoprotein testing market covered in this report is segmented –
1) By Type Of Apolipoprotein: Apolipoprotein A-I, Apolipoprotein B, Apolipoprotein E
2) By Technology: Immunoassays, Polymerase Chain Reaction (PCR)
3) By Application: Cardiovascular Disease Risk Assessment, Genetic Testing, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes
Subsegments:
1) By Apolipoprotein A-I: Quantitative Testing, Qualitative Testing, Functional Testing
2) By Apolipoprotein B: Total Apolipoprotein B Testing, Apolipoprotein B100 Testing, Apolipoprotein B48 Testing
3) By Apolipoprotein E: Genotyping Tests, Protein Level Testing, Functional Assays
Apolipoprotein Testing Market Industry Trends Fueling Future Revenue Growth
Leading firms within the apolipoprotein sector are launching advanced heart health initiatives, designed to offer more thorough evaluations and individualized guidance for cholesterol management and diminishing the threat of cardiovascular ailments. These improved wellness programs provide in-depth assessments and customized advice aimed at enhancing overall cardiovascular well-being. For example, in January 2023, InsideTracker, a US-based personal health analysis firm, incorporated Apolipoprotein B (ApoB) measurement, a crucial marker of heart health, into its Ultimate Plan. This addition allows users to gain a comprehensive understanding of their cardiovascular condition, given that elevated ApoB levels are linked to a greater likelihood of atherosclerosis and heart disease. The program provides individuals with data on their ApoB levels relative to typical ranges, along with customized lifestyle advice developed from extensive research by InsideTracker’s scientific team.
Apolipoprotein Testing Market Key Participants And Competitive Landscape
Major companies operating in the apolipoprotein testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Bio-Rad Laboratories Inc., Randox Laboratories Ltd., R&D Systems Inc., Elabscience Bionovation Inc., Sekisui Diagnostics LLC, RayBiotech Inc., Mabtech AB, Bioss Inc., Aviva Systems Biology Corporation, Abnova Corporation, DiaSys Diagnostic Systems GmbH, Enzo Life Sciences Inc., Eagle Biosciences Inc., CLOUD-CLONE CORP., ELK Biotechnology CO. Ltd., LifeSpan BioSciences Inc.,
View The Full Apolipoprotein Testing Market Report:
Apolipoprotein Testing Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the apolipoprotein testing market in 2025. The regions covered in the apolipoprotein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
